Literature DB >> 12120480

Threats in bioterrorism. I: CDC category A agents.

Robert G Darling1, Christina L Catlett, Kermit D Huebner, David G Jarrett.   

Abstract

Although once considered unlikely, bioterrorism is now a reality in the United States since the anthrax cases began appearing in the fall of 2001. Intelligence sources indicate there are many countries and terrorist organizations that either possess biological weapons or are attempting to procure them. In the future it is likely that we will experience additional acts of bioterrorism. The CDC category A agents represent our greatest challenge because they have the potential to cause grave harm to the medical and public health systems of a given population. Thus, it is imperative that plans be developed now to deal with the consequences of an intentional release of any one or more of these pathogens.

Entities:  

Mesh:

Year:  2002        PMID: 12120480     DOI: 10.1016/s0733-8627(02)00005-6

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  36 in total

Review 1.  Respiratory medical societies and the threat of bioterrorism.

Authors:  T G O'Riordan; G C Smaldone
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139

2.  Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals.

Authors:  Janie Parrino; Lewis H McCurdy; Brenda D Larkin; Ingelise J Gordon; Steven E Rucker; Mary E Enama; Richard A Koup; Mario Roederer; Robert T Bailer; Zoe Moodie; Lin Gu; Lihan Yan; Barney S Graham
Journal:  Vaccine       Date:  2006-11-07       Impact factor: 3.641

3.  Orthopoxvirus detection in environmental specimens during suspected bioterror attacks: inhibitory influences of common household products.

Authors:  Andreas Kurth; John Achenbach; Liljia Miller; Ian M Mackay; Georg Pauli; Andreas Nitsche
Journal:  Appl Environ Microbiol       Date:  2007-10-26       Impact factor: 4.792

4.  A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate.

Authors:  Larry A Gallagher; Elizabeth Ramage; Michael A Jacobs; Rajinder Kaul; Mitchell Brittnacher; Colin Manoil
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

5.  Crystal structure of UDP-glucose pyrophosphorylase from Yersinia pestis, a potential therapeutic target against plague.

Authors:  Morgan E Gibbs; George T Lountos; Rajesh Gumpena; David S Waugh
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-08-28       Impact factor: 1.056

6.  Efficient neutralization of antibody-resistant forms of anthrax toxin by a soluble receptor decoy inhibitor.

Authors:  Shilpi Sharma; Diane Thomas; John Marlett; Marianne Manchester; John A T Young
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  Genome-wide screen in Francisella novicida for genes required for pulmonary and systemic infection in mice.

Authors:  Petra S Kraemer; Allison Mitchell; Mark R Pelletier; Larry A Gallagher; Mike Wasnick; Laurence Rohmer; Mitchell J Brittnacher; Colin Manoil; Shawn J Skerett; Nina R Salama
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

8.  Pathema: a clade-specific bioinformatics resource center for pathogen research.

Authors:  Lauren M Brinkac; Tanja Davidsen; Erin Beck; Anuradha Ganapathy; Elisabet Caler; Robert J Dodson; A Scott Durkin; Derek M Harkins; Hernan Lorenzi; Ramana Madupu; Yinong Sebastian; Susmita Shrivastava; Mathangi Thiagarajan; Joshua Orvis; Jaideep P Sundaram; Jonathon Crabtree; Kevin Galens; Yongmei Zhao; Jason M Inman; Robert Montgomery; Seth Schobel; Kevin Galinsky; David M Tanenbaum; Adam Resnick; Nikhat Zafar; Owen White; Granger Sutton
Journal:  Nucleic Acids Res       Date:  2009-10-20       Impact factor: 16.971

9.  Advocacy, promotion and e-learning: Supercourse for zoonosis.

Authors:  Gino C Matibag; Manabu Igarashi; Ron E La Porte; Hiko Tamashiro
Journal:  Environ Health Prev Med       Date:  2005-09       Impact factor: 3.674

10.  NaxD is a deacetylase required for lipid A modification and Francisella pathogenesis.

Authors:  Anna C Llewellyn; Jinshi Zhao; Feng Song; Jyothi Parvathareddy; Qian Xu; Brooke A Napier; Hamed Laroui; Didier Merlin; James E Bina; Peggy A Cotter; Mark A Miller; Christian R H Raetz; David S Weiss
Journal:  Mol Microbiol       Date:  2012-09-11       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.